Popular on s4story
- People & Stories/Gente y Cuentos Announces New Board Leadership & Corporate Partnership Initiative - 135
- Mensa identifies best board games of 2025 - 130
- Electives Appoints DraftKings' CPO Linda Aiello to Board Amid Record Quarter - 105
- Is Billboard Advertising Still Effective in 2025?
- Two exciting new fantasy & adventure books are published
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet
- "The Eyes Have It" a Short Story by Philip K. Dick Now Available on Audiobook
- Fairfield Inn by Marriott Scottsdale Old Town Opens
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
Similar on s4story
- Asset-Backed Green Crypto: Fueling the Trillion-Dollar Revolution
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health
S For Story/10587436
SYDNEY, May 26, 2023 ~ FivepHusion, a clinical-stage biotechnology company, has announced a collaboration with Treehill Partners and Syneos Health® to develop and bring a novel, enhanced chemotherapeutic product to market.
Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, will provide FivepHusion with integrated business development, operational, strategic and transactional expertise. Syneos Health will support FivepHusion's integrated clinical development and commercialization capabilities. This collaboration is designed to strategically and optimally progress the development and commercialization of FivepHusion's enhanced chemotherapeutic formulation Deflexifol™ in global markets.
More on S For Story
Dr. Christian Toouli, CEO & Managing Director of FivepHusion said: "This is a very exciting time for FivepHusion. We are at a crucial stage in our growth strategy. By collaborating with Treehill Partners and Syneos Health, we believe we are positioned to successfully bring our development work on Deflexifol™ to global markets."
Christian Tucat, Chief Business Officer of Syneos Health added: "Leveraging our deep therapeutic and global expertise, Syneos Health is pleased to contribute to accelerating the clinical development and commercialization of this important new therapy."
Ali Pashazadeh, Partner & Co-founder of Treehill Partners commented: "This collaboration represents a new model of integrated services across disciplines designed to allow US and non-US emerging players to play a key role on the global stage."
The collaboration between these three industry leaders is intended to maximize progress on the development of Deflexifol™ and quickly bring innovative oncology medicines to patients in need.
Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, will provide FivepHusion with integrated business development, operational, strategic and transactional expertise. Syneos Health will support FivepHusion's integrated clinical development and commercialization capabilities. This collaboration is designed to strategically and optimally progress the development and commercialization of FivepHusion's enhanced chemotherapeutic formulation Deflexifol™ in global markets.
More on S For Story
- Inspiring memoir about growing up well with good support & guidance
- Historical Fantasy 'Keeper of the Hollow' Weaves Faith, Mystery, and Mountain Magic
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- I Turned Mom into a Popsicle! Hits the Shelves
Dr. Christian Toouli, CEO & Managing Director of FivepHusion said: "This is a very exciting time for FivepHusion. We are at a crucial stage in our growth strategy. By collaborating with Treehill Partners and Syneos Health, we believe we are positioned to successfully bring our development work on Deflexifol™ to global markets."
Christian Tucat, Chief Business Officer of Syneos Health added: "Leveraging our deep therapeutic and global expertise, Syneos Health is pleased to contribute to accelerating the clinical development and commercialization of this important new therapy."
Ali Pashazadeh, Partner & Co-founder of Treehill Partners commented: "This collaboration represents a new model of integrated services across disciplines designed to allow US and non-US emerging players to play a key role on the global stage."
The collaboration between these three industry leaders is intended to maximize progress on the development of Deflexifol™ and quickly bring innovative oncology medicines to patients in need.
Filed Under: Business
0 Comments
Latest on S For Story
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
- Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
- Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Sci-Fi Author Christian Hurst on Creativity, Resilience, and Making Art Anyway
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands